Krystal Biotech (KRYS) Research & Development (2021 - 2025)
Historic Research & Development for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to $14.8 million.
- Krystal Biotech's Research & Development rose 935.84% to $14.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $58.0 million, marking a year-over-year increase of 833.15%. This contributed to the annual value of $58.0 million for FY2025, which is 833.33% up from last year.
- Latest data reveals that Krystal Biotech reported Research & Development of $14.8 million as of Q4 2025, which was up 935.84% from $14.6 million recorded in Q3 2025.
- Over the past 5 years, Krystal Biotech's Research & Development peaked at $15.6 million during Q2 2024, and registered a low of $6.1 million during Q3 2021.
- For the 5-year period, Krystal Biotech's Research & Development averaged around $11.4 million, with its median value being $11.4 million (2022).
- In the last 5 years, Krystal Biotech's Research & Development surged by 8940.79% in 2022 and then plummeted by 1083.17% in 2024.
- Over the past 5 years, Krystal Biotech's Research & Development (Quarter) stood at $9.0 million in 2021, then increased by 19.23% to $10.7 million in 2022, then rose by 5.87% to $11.4 million in 2023, then rose by 18.96% to $13.5 million in 2024, then rose by 9.36% to $14.8 million in 2025.
- Its Research & Development stands at $14.8 million for Q4 2025, versus $14.6 million for Q3 2025 and $14.4 million for Q2 2025.